JPMorgan Upgrades Adient (ADNT) to Overweight

JPMorgan analyst Rajat Gupta upgraded Adient (NYSE: ADNT) from Neutral to Overweight with a price target of $25.00 (from $28.00).

For an analyst ratings summary and ratings history on Adient click here. For more ratings news on Adient click here.

Shares of Adient closed at $18.76 yesterday.

You May Also Be Interested In

• Chord Energy Corp (CHRD) PT Lowered to $184 at UBS on Model Updates Following Non-Core Marcellus Sale
• Astra International Tbk PT (ASII:IJ) (PTAIY) PT Lowered to IDR6,450 at JPMorgan
• Jointown Pharmaceutical Group Co Ltd. (600998:CH) PT Raised to RMB23.50 at JPMorgan